E-LIB Suche - Ergebnisse für: Socinski, Mark A

1

Combined use of CYFRA 21-1 and CA 125 predicts survival of ..:

Mang, Anika ; Zou, Wei ; Rolny, Vinzent...
Tumor Biology. 46 (2024) s1 - p. S177-S190 , 2024

Link: https://doi.org/10.3233/..

2

A lack of association between BMI and chemoimmunotherapy ef..:

Li, Lee X. ; Socinski, Mark A. ; Kichenadasse, Ganessan...
BMC Cancer. 24 (2024) 1 - p. , 2024

Link: https://doi.org/10.1186/..

3

Phase II Randomized Trial of Carboplatin, Pemetrexed, and B..:

Bodor, J. Nicholas ; Patel, Jyoti D. ; Wakelee, Heather A....
Clinical Lung Cancer. 24 (2023) 7 - p. e242-e246 , 2023

Link: https://doi.org/10.1016/..

4

Circulating Tumor DNA Monitoring on Chemo-immunotherapy for..:

Pellini, Bruna ; Madison, Russell W. ; Childress, Merrida A....
Clinical Cancer Research. 29 (2023) 22 - p. 4596-4605 , 2023

Link: https://doi.org/10.1158/..

5

A phase II clinical trial evaluating the safety and efficac..:

Shaverdashvili, Khvaramze ; Reyes, Vincent ; Wang, Hong...
eClinicalMedicine. 66 (2023) - p. 102317 , 2023

Link: https://doi.org/10.1016/..

6

Guidance for clinicians and patients with non-small cell lu..:

Villaruz, Liza C. ; Socinski, Mark A. ; Weiss, Jared
Frontiers in Oncology. 13 (2023) - p. , 2023

Link: https://doi.org/10.3389/..

7

Poziotinib in Treatment-Naive NSCLC Harboring HER2 Exon 20 ..:

Cornelissen, Robin ; Prelaj, Arsela ; Sun, Sophie...
Journal of Thoracic Oncology. 18 (2023) 8 - p. 1031-1041 , 2023

Link: https://doi.org/10.1016/..

8

Impact of gender and mutational differences in hormone rece..:

Hsu, Robert ; Chen, Denaly ; Xia, Bing...
Frontiers in Oncology. 13 (2023) - p. , 2023

Link: https://doi.org/10.3389/..

9

Low Risk of Hyperprogression with First-Line Chemoimmunothe..:

Li, Lee X ; Cappuzzo, Federico ; Matos, Ignacio...
The Oncologist. 28 (2023) 4 - p. e205-e211 , 2023

Link: https://doi.org/10.1093/..

10

Pan-tumor survey of RET fusions as detected by next-generat..:

Nagasaka, Misako ; Brazel, Danielle ; Baca, Yasmine...
Translational Oncology. 36 (2023) - p. 101744 , 2023

Link: https://doi.org/10.1016/..

11

PD.01.01 Acquired EGFR Resistant Mutations and Co-mutations..:

Raez, Luis E. ; Baca, Yasmine ; Carracedo, Carlos...
Journal of Thoracic Oncology. 18 (2023) 3 - p. S3 , 2023

Link: https://doi.org/10.1016/..

12

A longitudinal circulating tumor DNA-based model associated..:

Assaf, Zoe June F. ; Zou, Wei ; Fine, Alexander D....
Nature Medicine. 29 (2023) 4 - p. 859-868 , 2023

Link: https://doi.org/10.1038/..

13

Population Pharmacokinetics of MYL-1402O, a Proposed Biosim..:

Owen, Joel S. ; Rackley, Russell J. ; Hummel, Matthew A....
European Journal of Drug Metabolism and Pharmacokinetics. 48 (2023) 6 - p. 675-689 , 2023

Link: https://doi.org/10.1007/..

14

IMpower150 Final Exploratory Analyses for Atezolizumab Plus..:

Nogami, Naoyuki ; Barlesi, Fabrice ; Socinski, Mark A....
Journal of Thoracic Oncology. 17 (2022) 2 - p. 309-323 , 2022

Link: https://doi.org/10.1016/..

15

The Applicability of the Results in the Asian Population of..:

Liu, Stephen V. ; Nagasaka, Misako ; Stefaniak, Victoria...
Frontiers in Oncology. 12 (2022) - p. , 2022

Link: https://doi.org/10.3389/..